Health care conglomerate CVS Health is looking to leverage technology and artificial intelligence to drive down health costs.

The corporations that pay for private employee health insurance are not ready to swallow the high costs of the enormously ...

A new CVS Caremark settlement caps insulin costs and sets up a deductible change for TrumpRx purchases. Here's what's in the ...

Allegations leveled against CVS Caremark accused the PBM of preferring more expensive versions of insulin in order to boost ...

Shares of CVS Health closed slightly higher Tuesday, about a quarter of a percentage point.

The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from ...

Insurance carriers need more proof that paying today’s GLP-1 drug prices will create “enough downstream savings,” assuming ...

Development opportunities help employees pursue career paths and apply new skills that align with essential company roles.

A new FTC settlement with CVS Caremark could lower prescription costs for some Georgia patients and save consumers billions over the next decade.

The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different ...

After years of rampant expansion into nearly every corner of the healthcare system, the biggest insurance conglomerates are ...

On July 1, 2026, long-term care pharmacy Omnicare, LLC disclosed that Omnicare and its parent company CVS Health Corporation (CVS) reached a ...